Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
Conference Paper
Full Text
Duke Authors
Cited Authors
- Keystone, E; Van der Heijde, D; Smolen, J; Weinblatt, M; Kvien, T; Strand, V; Ansari, Z; Goel, N; Combe, B
Published Date
- June 1, 2010
Published In
Volume / Issue
- 37 / 6
Start / End Page
- 1333 - 1333
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0315-162X
Conference Name
- 65th Annual Meeting of the Canadian-Rheumatology-Association
Conference Location
- Quebec, CANADA
Conference Start Date
- February 3, 2010
Conference End Date
- February 6, 2010